IMVT

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Immunovant (IMVT) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

IMVT is expected to report earnings to fall 11.92% to -57 cents per share on February 12

Q4'24

Est.

$-0.58

Q3'24

Missed

by $0.06

Q2'24

Est.

$-0.52

Q1'24

Missed

by $0.09

Q4'23

Beat

by $0.07

The last earnings report on November 07 showed earnings per share of -65 cents, missing the estimate of -58 cents. With 1.08M shares outstanding, the current market capitalization sits at 4.12B.

View a ticker or compare two or three

Compare

IMVT

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For IMVT
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for IMVT (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a clinical-stage biopharmaceutical company, which focuses on enabling normal lives for patients with autoimmune diseases.

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

320 West 37th Street

Phone

+1 917 580-3099

Employees

164

Web

https://www.immunovant.com